Skip to main content
Live · TradingView
Back to the NewsWire

Psychiatrictimes

Published September 15, 2026 · Updated September 16, 2026

FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval

Read the full story at Psychiatrictimes

FDA hearing spotlights debates over psychedelic therapy: who administers, how to prove efficacy, and how to track safety as approvals near.

Surfaced by this Google Alert

  • Psychedelics